Top

Published in:

01-12-2017 | Brief Communication

Acute toxic leukoencephalopathy associated with a non-prescription weight loss supplement: a report of two cases

Authors: Cesar E. Escamilla-Ocañas, Carlos R. Cámara-Lemarroy, Leonel Cantú-Martinez, Héctor R. Martínez

Published in: Neurological Sciences | Issue 12/2017

Abstract

Weight loss dietary supplements are used with some frequency by an increasingly overweight population. Some products are not adequately regulated and may pose potential health risks. We report two new cases of acute toxic leukoencephalopathy (ATL) due to the use of a supplement marketed as a thermogenic weight loss aid. ATL is a heterogeneous clinic-radiological entity that has been associated with various compounds, such as chemotherapeutic drugs and immunomodulators. It is characterized by an often reversible periventricular and infratentorial demyelination. The commercialization of non-regulated weight loss products continues to be a health risk in our population.

Lira-García C, Souto-Gallardo M, Bacardí-Gascón M et al (2008) Revisión de la efectividad de los ingredientes de productos alternativos para la pérdida de peso. Rev Salud pública 10:818–830CrossRefPubMed

Timbo BB, Ross MP, McCarthy PV et al (2006) Dietary supplements in a national survey: prevalence of use and reports of adverse events. J Am Diet Assoc 106:1966–1974CrossRefPubMed

Filley CM, Kleinschmidt-Demasters BK (2001) Toxic leukoencephalopathy. N Engl J Med 345:425–432CrossRefPubMed

Rimkus Cde M, Andrade CS, Leite Cda C et al (2014) Toxic leukoencephalopathies, including drug, medication, environmental, and radiation-induced encephalopathic syndromes. Semin Ultrasound CT MR 35:97–117CrossRefPubMed

Olivas-Chacón CI, Treviño-García M, Chua-Tjuan JJ et al (2015) Leukoencephalopathy changes on magnetic resonance imaging associated with a thermogenic dietary supplement (Thermatrim). Porc (Bay Univ Med Cent) 28:389–391

McKinney AM, Kieffer SA, Paylor RT et al (2009) Acute toxic leukoencephalopathy: potential for reversibility clinically and on MRI with diffusion-weighted and FLAIR imaging. AJR Am J Roentgenol 193:192–206CrossRefPubMed

Osuna MT, Querol L, Olivas-Chacón CI et al (2015) Neuropatía desmielinizante y leucoencefalopatía tóxicas en pacientes que toman los productos adelgazantes Thermatrim® y Pura Alegría®. Rev Neurol 61:527–528PubMed

Da Silva WV, de Andrade Gomes Silva MI, Tavares Toscano L et al (2014) Supplementation prevalence and adverse effects in physical exercise practitioners. Nut Hosp 29:158–165

https://www.gob.mx/cms/uploads/attachment/file/130732/8_Alerta_sanitaria_THERMATRIM_02122014.pdf. Accessed on 21 Feb 2017

Title: Acute toxic leukoencephalopathy associated with a non-prescription weight loss supplement: a report of two cases
Authors: Cesar E. Escamilla-Ocañas
Carlos R. Cámara-Lemarroy
Leonel Cantú-Martinez
Héctor R. Martínez
Publication date: 01-12-2017
Publisher: Springer Milan
Published in: Neurological Sciences / Issue 12/2017
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI: https://doi.org/10.1007/s10072-017-3028-0

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Acute toxic leukoencephalopathy associated with a non-prescription weight loss supplement: a report of two cases

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 12/2017

Vascular parkinsonism or idiopathic NPH? New insights from CSF pressure analysis

An exploratory study of the electronic medical record and outpatient vascular neurology consultations

Caspr2 antibodies in a patient with prostate cancer: a cognitive deterioration with recurrent and paroxysmal gait ataxia and aphasia

Wilson’s disease presenting as central pontine myelinolysis

Hub-and-spoke stroke network in the Veneto region: a retrospective study investigating the effectiveness of the stroke pathway and trends over time

Contribution of auditory P300 test to the diagnosis of mild cognitive impairment in Parkinson’s disease